MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance : Melanoma Research

Journal Logo

Original Articles: Basic Science

MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance

Rao, Dishaa; Lacroix, Rubena; Rooker, Alexa; Gomes, Taináa; Stunnenberg, Johanna A.a; Valenti, Meselea; Dimitriadis, Petrosa; Lin, Chun-Pua; de Bruijn, Beaunellea; Krijgsman, Oscara; Ligtenberg, Maarten A.a; Peeper, Daniel S.a,b; Blank, Christian U.a,c,d

Author Information
Melanoma Research 33(1):p 12-26, February 2023. | DOI: 10.1097/CMR.0000000000000863

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid